It is possible that ZEB1 may stimulate glycolysis by simultaneously activating PFKM and inhibiting FBP1 transcription in HCC, and the later postulation should be further investigated in HCC in the future. The gene discussed is FBP1; the disease is hepatocellular carcinoma.